Jonker, Emile F Fvan Ravenhorst, Mariëtte BBerbers, Guy A MVisser, Leo G2018-05-272018-05-272018-05-16Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines. 2018 Vaccine1873-25182977851510.1016/j.vaccine.2018.05.064http://hdl.handle.net/10029/621950Vaccination with conjugated meningococcal vaccines is the best way to prevent invasive meningococcal disease. Changes in serogroup epidemiology have led to the inclusion of quadrivalent vaccines in the national immunization programs of several countries, but vaccines are frequently in short supply. Intradermal administration has the potential to increase vaccine availability through dose reduction, without sacrificing efficacy. It has never before been investigated for glycoconjugate meningococcal vaccines.eninfo:eu-repo/semantics/closedAccessArticleVaccine 2018; advance online publication (ahead of print)